91
Participants
Start Date
October 31, 2014
Primary Completion Date
April 20, 2016
Study Completion Date
April 20, 2016
Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO Z
IM injection of Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO Z):
Booster-MVA-BN® Filo or saline placebo
IM injection of Booster-MVA-BN® Filo or saline placebo
Center for Vaccine Development, Mali, Bamako
Collaborators (1)
Wellcome Trust
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Leidos Biomedical Research, Inc.
INDUSTRY
University of Maryland, Baltimore
OTHER